ETTLINGEN, Germany – November 07, 2022 – Bruker announces the launch of the Fourier 80 ChemLab with Mixture Profiling module, an easy-to-deploy benchtop solution that uses nuclear magnetic resonance (NMR) to enhance production efficiency in chemical industry manufacturing.
This new end-to-end solution combines Bruker’s high-performance benchtop NMR system with fully automated software for data interpretation and report generation. Chemical manufacturing requires extensive testing from incoming raw materials through processing to final product quality control. NMR provides a valuable, comprehensive tool to identify multiple compounds in a chemical mixture in a single measurement, providing industrial manufacturers with a new end-to-end solution for small molecule analysis
The Fourier 80 ChemLab with Mixture Profiling module expands the potential of NMR analysis to the routine laboratory. This push-button chemical profiling solution can be easily adapted to resolve new analytical questions. The instrument provides detailed reports that identify and quantify the constituents in a specific raw material, process intermediate, or product formulation, enabling continuous monitoring throughout the entire production process. Correlating these readings with other process parameters leads to increased efficiency in terms of material and energy consumption, and overall synthesis performance.
The inherently quantitative technology of NMR comes without requiring substance-specific reference material or calibration. The technology can be used by both trained professionals and new users, making the whole manufacturing affiliated environment more efficient and accurate from an end-to-end perspective, maximizing time-to-result and production flexibility.
Product innovation within the chemical industry must respond rapidly to external triggers such as regulatory aspects, supply chain changes, and competitive challenges. Rolling out a new product formulation into manufacturing also requires rapid adaption of the analytical testing landscape throughout the whole value chain. Being able to utilize the same analytical technology, such as NMR, throughout the value chain can significantly speed up the validation and integration process. The Fourier 80 ChemLab with Mixture Profiling module forms part of Bruker’s unique Distributed Laboratory Topology (DLT) concept that links methodologies of high-resolution floor-standing NMR instruments with easy-to-deploy benchtop units. This concept includes coherent data generation and global data sharing in real time, consistent audit trails, reduced time-to-result, and enhanced training synergies.
Dr. Joerg Koehler, Head of Business Unit Industrial at Bruker BioSpin, commented: “Our customers streamline their diverse analytical testing landscapes by smart deployment strategies within the Distributed Laboratory Topology concept, which allows for seamless workflows in product innovation, pilot and volume manufacturing. Our close cooperation with industrial market leaders ensures that existing pain points in various workflows are addressed in an optimal way.”
Deploying new testing methods based on benchtop NMR in manufacturing environments requires user independent operation, where automated data processing and report generation are key. The Mixture Profiling Module on Bruker’s Fourier 80 instrument series delivers the advantages of NMR at any stage of the production process in due time.”
To find out more information about the Fourier 80 ChemLab with Mixture Profiling module, please visit web page.
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
Dr. Joerg Koehler
Head of Business Unit Industrial